Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); EROS Pod On Track for Approval in Q3/12

Canaccord Genuity reiterates a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target of $27.00.

Analyst, William J. Plovanic, said, "We recently traveled with management from Insulet on a non-deal road show and came away with more clarity regarding 2012 catalysts, including the regulatory status of the next generation OmniPod (Eros), potential for margin improvement upon commercialization, and a longer-term view of the product pipeline."

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $20.86 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
• Spotify (SPOT) PT Raised to $330 at Canaccord Genuity
• Braze Inc (BRZE) PT Lowered to $50 at Canaccord Genuity